Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LSN3321213 + LY3499446 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LSN3321213 | LSN-3321213|LSN 3321213 | Aurka Inhibitors 27 | LSN3321213 inhibits Aurora Kinase A inhibitor, which potentially results in increased tumor cell apoptosis (Cancer Res (2023) 83 (7_Supplement): 3868). | |
LY3499446 | LY-3499446|LY 3499446 | KRAS G12C inhibitor 34 | LY3499446 is an oral inhibitor of KRAS G12C that prevents constitutive downstream signaling to inhibit tumor cell proliferation and growth (PMID: 32014824). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|